Combating Autism Act
Combating Autism Act is a significant piece of legislation in the United States that was signed into law by President George W. Bush on December 19, 2006. The Act, officially known as Public Law 109-416, was designed to address the urgent need for a nationwide effort to combat autism through research, screening, intervention, and education.
Background[edit | edit source]
The Combating Autism Act was introduced in response to the increasing prevalence of autism in the United States. According to the Centers for Disease Control and Prevention (CDC), the prevalence of autism has increased significantly over the past two decades, with current estimates suggesting that one in every 54 children in the U.S. is diagnosed with an autism spectrum disorder (ASD).
Provisions[edit | edit source]
The Act authorized nearly $1 billion over five years to increase funding for autism research, screening, intervention, and education. It also called for the establishment of Centers of Excellence for Autism Spectrum Disorder Research and Epidemiology.
Impact[edit | edit source]
The Combating Autism Act has had a significant impact on the autism community. It has led to increased research funding, which has resulted in a better understanding of the causes and treatments for autism. The Act has also led to improvements in the early detection and intervention of autism, which are critical to improving outcomes for individuals with autism.
Reauthorization[edit | edit source]
The Combating Autism Act was reauthorized in 2011 as the Combating Autism Reauthorization Act (CARA), and again in 2014 as the Autism CARES Act. The Autism CARES Act, which stands for Collaboration, Accountability, Research, Education, and Support, continues the work started by the Combating Autism Act and ensures that the federal government continues to help meet the needs of individuals with autism and their families.
See also[edit | edit source]
References[edit | edit source]
.svg){kind=small} | This United States government–related article is a stub. You can help WikiMD by expanding it. |
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
